NFKB1 and prostate carcinoma: suggested that HMGB1 promotes EMT in prostate cancer PC3 cells by activating the RAGE/NF-κB signaling pathway, upregulating the expression of EMT markers MMP-1, MMP-3, and MMP-10, and promoting prostate cancer metastasis (116).